APA

Nakamoto H., Fujita T., Origasa H., Isono M., Kurumatani H., Okada K., Kanoh H., Kiriyama T. & Yamada S. (20150330). A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design. : BMC nephrology.

Chicago

Nakamoto Hidetomo, Fujita Toshiro, Origasa Hideki, Isono Masanao, Kurumatani Hajimu, Okada Kiyonobu, Kanoh Hiroyuki, Kiriyama Takashi and Yamada Shunsuke. 20150330. A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design. : BMC nephrology.

Harvard

Nakamoto H., Fujita T., Origasa H., Isono M., Kurumatani H., Okada K., Kanoh H., Kiriyama T. and Yamada S. (20150330). A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design. : BMC nephrology.

MLA

Nakamoto Hidetomo, Fujita Toshiro, Origasa Hideki, Isono Masanao, Kurumatani Hajimu, Okada Kiyonobu, Kanoh Hiroyuki, Kiriyama Takashi and Yamada Shunsuke. A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design. : BMC nephrology. 20150330.